Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Strata Critical MedicalSRTAW 74 EV-to-OCF is 0.00 as of Sep. 11, 2026. GuruFocus rates SRTAW with a GF Score™ of 74/100. The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Strata Critical Medical ranks better than 86.38% on this metric.
The historical rank and industry rank for Strata Critical Medical's EV-to-OCF or its related term are showing as below:
SRTAW'
s EV-to-OCF Range Over the Past 10 Years
Min: -216267 Med: -6.71 Max: 278.13
Current: -12.03
During the past 7 years, the highest EV-to-OCF of Strata Critical Medical was 278.13. The lowest was -216267.00. And the median was -6.71.
SRTAW's EV-to-OCF is ranked better than 86.38% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 8.8
vs SRTAW: -12.03
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Strata Critical Medical (NAS:SRTAW) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Strata Critical Medical's PE Ratio (TTM) for today is calculated as:
Strata Critical Medical's share price for today is $0.035.
Strata Critical Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Strata Critical Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's EV-to-OCF falls into.
Strata Critical Medical's current Enterprise Value is $0.00 Mil.
Strata Critical Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-36.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strata Critical Medical (SRTAW) has a EV-to-OCF of 0.00 as of Sep. 11, 2026. According to the industry distribution chart, Strata Critical Medical ranks #93 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 13.6%.
Is Strata Critical Medical's EV-to-OCF too high?
Strata Critical Medical's current EV-to-OCF is 0.00. Based on the distribution chart, Strata Critical Medical ranks #93 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Strata Critical Medical has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's EV-to-OCF compare to STLN and CYH?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #93 out of 683 companies for EV-to-OCF. This places Strata Critical Medical in the top 14% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 8.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.80, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current EV-to-OCF is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Strata Critical Medical (SRTAW) has a current EV-to-OCF of 0.00. The current EV-to-OCF is 0.00. Strata Critical Medical's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Strata Critical Medical (SRTAW), the current EV-to-OCF is 0.00 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
74GF Score
Get the complete analysis for SRTAW
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTAW has been successfully added to your 
